BNP Paribas Arbitrage SA lowered its stake in shares of Luminex Corp. (NASDAQ:LMNX) by 47.6% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,551 shares of the company’s stock after selling 5,940 shares during the period. BNP Paribas Arbitrage SA’s holdings in Luminex Corp. were worth $149,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently made changes to their positions in LMNX. Vanguard Group Inc. raised its position in Luminex Corp. by 2.9% in the second quarter. Vanguard Group Inc. now owns 3,059,081 shares of the company’s stock worth $61,885,000 after buying an additional 86,935 shares during the last quarter. BlackRock Fund Advisors raised its position in Luminex Corp. by 1.6% in the first quarter. BlackRock Fund Advisors now owns 3,017,364 shares of the company’s stock worth $58,537,000 after buying an additional 46,200 shares during the last quarter. RGM Capital LLC raised its position in Luminex Corp. by 15.8% in the first quarter. RGM Capital LLC now owns 1,645,903 shares of the company’s stock worth $31,931,000 after buying an additional 225,055 shares during the last quarter. Acadian Asset Management LLC raised its position in Luminex Corp. by 16.5% in the second quarter. Acadian Asset Management LLC now owns 1,622,291 shares of the company’s stock worth $32,819,000 after buying an additional 229,781 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its position in Luminex Corp. by 15.9% in the second quarter. Dimensional Fund Advisors LP now owns 1,437,400 shares of the company’s stock worth $29,078,000 after buying an additional 197,506 shares during the last quarter. 79.85% of the stock is owned by institutional investors and hedge funds.
Shares of Luminex Corp. (NASDAQ:LMNX) opened at 23.17 on Monday. The firm’s 50-day moving average price is $21.91 and its 200-day moving average price is $20.87. Luminex Corp. has a 52-week low of $17.29 and a 52-week high of $23.75. The stock has a market cap of $1.01 billion, a P/E ratio of 24.19 and a beta of 0.42.
Luminex Corp. (NASDAQ:LMNX) last released its quarterly earnings data on Thursday, July 28th. The company reported $0.33 EPS for the quarter, beating the consensus estimate of $0.15 by $0.18. Luminex Corp. had a net margin of 16.60% and a return on equity of 13.65%. The business earned $64.20 million during the quarter, compared to the consensus estimate of $61.20 million. During the same quarter in the prior year, the firm earned $0.27 EPS. The business’s revenue was up 8.9% on a year-over-year basis. Equities analysts predict that Luminex Corp. will post $0.63 EPS for the current year.
A number of equities analysts have recently commented on LMNX shares. Zacks Investment Research lowered Luminex Corp. from a “buy” rating to a “hold” rating in a report on Monday, July 4th. JPMorgan Chase & Co. raised Luminex Corp. from an “underweight” rating to a “neutral” rating and lifted their price objective for the company from $18.00 to $22.00 in a research note on Thursday, August 18th. Finally, Jefferies Group lifted their price objective on Luminex Corp. from $21.00 to $23.00 and gave the company a “hold” rating in a research note on Thursday, July 28th. Six analysts have rated the stock with a hold rating, Luminex Corp. presently has a consensus rating of “Hold” and a consensus price target of $22.20.
About Luminex Corp.
Luminex Corporation develops, manufactures and sells biological testing technologies with applications throughout the diagnostics, pharmaceutical and life sciences industries. The Company has a range of instruments using its xMAP technology, including its LUMINEX 100/200 systems offer 100-plex testing; the Company’s FLEXMAP 3D system is its high-throughput, 500-plex testing system, and its MAGPIX system provides 50-plex testing using imaging rather than flow cytometry.
Want to see what other hedge funds are holding LMNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Luminex Corp. (NASDAQ:LMNX).
Receive News & Ratings for Luminex Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Luminex Corp. and related companies with MarketBeat.com's FREE daily email newsletter.